A2A Adenosine Receptors and Equine Sepsis

Award Information
Agency:
Department of Agriculture
Amount:
$296,000.00
Program:
SBIR
Contract:
2006-33610-17725
Solitcitation Year:
N/A
Solicitation Number:
N/A
Branch:
N/A
Award Year:
2006
Phase:
Phase II
Agency Tracking Number:
2003-00471
Solicitation Topic Code:
N/A
Small Business Information
Adenosine Therapeutics, LLC
1670 Discovery Dr., Ste. 212, Charlottesville, VA, 22911
Hubzone Owned:
N
Woman Owned:
N
Socially and Economically Disadvantaged:
N
Duns:
N/A
Principal Investigator
 Robert Thompson
 (434) 951-9484
 rdt@adenrx.com
Business Contact
 Robert Capon
Title: CEO
Phone: (434) 220-9400
Email: rob@adenrx.com
Research Institution
N/A
Abstract
Endotoxemia (Sepsis) affects horses of all breeds and ages and is the leading causes of death in adult horses and foals. Consequently, its economic impact on the equine industry in the United States is devastating. This project seeks to develop new treatments for this disease.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government